An Open-label, Single-dose Pilot Study to Evaluate Varisolve® (Polidocanol Endovenous Microfoam (PEM)) 0.125% [0.2%] for Varicose Veins

NCT00928421 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Varicose Veins

Interventions

DRUG: Polidocanol Endovenous Microfoam 0.125%

Sponsor

Boston Scientific Corporation